{'fraction_non_alphanumeric': 0.026976744186046512, 'fraction_numerical': 0.013023255813953489, 'mean_word_length': 5.404761904761905, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
It's 'north to Alaska' for research on some vaccines by infectious diseases staff.

ABSTRACT NATIVE ALASKANS are important allies to CDC epidemiologists.High rates of hepatitis B and Haemophilus influenzae infection plague the Inuit (commonly called Eskimo), Aleut and Indian populations, providing unique opportunities for focused study.The Center for Infectious Diseases keeps 14 full-time employees at its Arctic Investigations Program field station in Anchorage.The effective use of hepatitis B vaccine was first demonstrated here, despite the "tremendous distances and logistic problems" inherent in studying a population spread over 200 different communities, some as far as 500 frozen miles (800 km) from major medical centers, says director Ann Lanier, MD, MPH. Since only 15% of Alaska is accessible by road, researchers had to fly in and out of villages to collect blood samples, perform laboratory screens for exposure, administer vaccine, and then retest for immunogenicity.Now 7 years out, the study is continuing to follow up patients to see when a booster shot